BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34944969)

  • 1. Side-by-Side Comparison of Five Chelators for
    Damerow H; Hübner R; Judmann B; Schirrmacher R; Wängler B; Fricker G; Wängler C
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Optimized
    Damerow H; Cheng X; von Kiedrowski V; Schirrmacher R; Wängler B; Fricker G; Wängler C
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iEDDA Conjugation Reaction in Radiometal Labeling of Peptides with
    Litau S; Seibold U; Wängler B; Schirrmacher R; Wängler C
    ACS Omega; 2018 Oct; 3(10):14039-14053. PubMed ID: 30411057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for
    Seibold U; Wängler B; Wängler C
    ChemMedChem; 2017 Sep; 12(18):1555-1571. PubMed ID: 28715615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and in vitro evaluation of new bifunctional
    Klasen B; Lemcke D; Mindt TL; Gasser G; Rösch F
    Nucl Med Biol; 2021; 102-103():12-23. PubMed ID: 34242949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
    Deri MA; Ponnala S; Zeglis BM; Pohl G; Dannenberg JJ; Lewis JS; Francesconi LC
    J Med Chem; 2014 Jun; 57(11):4849-60. PubMed ID: 24814511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a Bifunctional Cross-Bridged Chelating Agent, Peptide Conjugation, and Comparison of
    Damerow H; Wängler B; Schirrmacher R; Fricker G; Wängler C
    ChemMedChem; 2023 Jan; 18(1):e202200495. PubMed ID: 36259364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.
    Deri MA; Ponnala S; Kozlowski P; Burton-Pye BP; Cicek HT; Hu C; Lewis JS; Francesconi LC
    Bioconjug Chem; 2015 Dec; 26(12):2579-91. PubMed ID: 26550847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Evaluation of DFO-Em: A Modular Chelator with Octadentate Chelation for Optimal Zirconium-89 Radiochemistry.
    Salih AK; Raheem SJ; Garcia MD; Ahiahonu WK; Price EW
    Inorg Chem; 2022 Dec; 61(51):20964-20976. PubMed ID: 36516446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Click-to-Release: Cleavable Radioimmunoimaging with [
    Vlastara M; Rossin R; Hoeben FJM; de Roode KE; Boswinkel M; Kleijn LHJ; Nagarajah J; Rijpkema M; Robillard MS
    Theranostics; 2023; 13(12):4004-4015. PubMed ID: 37554267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of
    Imura R; Ida H; Sasaki I; Ishioka NS; Watanabe S
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing
    Cho H; Al-Saden N; Lam H; Möbus J; Reilly RM; Winnik MA
    Nucl Med Biol; 2020; 84-85():11-19. PubMed ID: 31931305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
    Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
    J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of DFO-HOPO as an octadentate chelator for zirconium-89.
    Allott L; Da Pieve C; Meyers J; Spinks T; Ciobota DM; Kramer-Marek G; Smith G
    Chem Commun (Camb); 2017 Jul; 53(61):8529-8532. PubMed ID: 28703825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional Desferrichrome Analogues as Versatile
    Adams CJ; Wilson JJ; Boros E
    Mol Pharm; 2017 Aug; 14(8):2831-2842. PubMed ID: 28665620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89.
    Zhai C; He S; Ye Y; Rangger C; Kaeopookum P; Summer D; Haas H; Kremser L; Lindner H; Foster J; Sosabowski J; Decristoforo C
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30845658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular
    Buchwalder C; Jaraquemada-Peláez MG; Rousseau J; Merkens H; Rodríguez-Rodríguez C; Orvig C; Bénard F; Schaffer P; Saatchi K; Häfeli UO
    Inorg Chem; 2019 Nov; 58(21):14667-14681. PubMed ID: 31633347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the complexation of
    Guérard F; Beyler M; Lee YS; Tripier R; Gestin JF; Brechbiel MW
    Dalton Trans; 2017 Apr; 46(14):4749-4758. PubMed ID: 28338136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89.
    Sarbisheh EK; Salih AK; Raheem SJ; Lewis JS; Price EW
    Inorg Chem; 2020 Aug; 59(16):11715-11727. PubMed ID: 32799484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.